Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-24-000004

Chief Scientific Officer gave up 2,351 shares (to pay taxes)

  • Chief Scientific Officer acquired 5,734 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Humeau Laurent · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-26 Exercise or conversion : show line 1 in the form +1,878 19,764 D
2024-02-26 Shares withheld for taxes : show line 2 in the form −770 $8.16 $6,283 18,994 D
2024-02-26 Exercise or conversion : show line 3 in the form +3,856 22,850 D
2024-02-26 Shares withheld for taxes : show line 4 in the form −1,581 $8.16 $12,901 21,269 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-02-26 Exercise or conversion : show line 5 in the form Restricted Stock Unit −1,878 0 D
2024-02-26 Exercise or conversion : show line 6 in the form Restricted Stock Unit −3,856 3,855 D
2024-02-28 Grant or award : show line 7 in the form Common Stock Option +18,750 18,750 D
2024-02-28 Grant or award : show line 8 in the form Restricted Stock Unit +15,029 15,029 D
Loading xslF345X05/wk-form4_1709158046.xml…